Skip to main content
. 2022 Apr 20;17(4):e0265928. doi: 10.1371/journal.pone.0265928

Table 3. Least square means and mean difference of change on the physical component summary of the HRQoL (univariate analysis).

Overall Change Received antidepressant medication
Yes No
Year Baseline Follow-up Mean Difference Baseline Follow-up Mean Difference Baseline Follow-up Mean Difference p-value*
2005 43.59 42.95 - 0.64 43.25 42.89 - 0.36 44.05 43.05 - 1.00 0.3418
2006 44.38 44.00 - 0.38 42.74 42.38 - 0.36 46.58 46.17 - 0.41 0.9297
2007 45.09 44.72 - 0.37 44.12 44.24 0.12 46.54 45.44 - 1.10 0.1313
2008 44.12 43.57 - 0.55 43.89 43.29 - 0.60 44.42 43.95 - 0.47 0.8284
2009 44.40 43.81 - 0.59 43.09 42.93 - 0.16 46.08 44.96 - 1.12 0.1397
2010 44.29 43.71 - 0.58 43.53 42.85 - 0.68 45.24 44.78 - 0.46 0.7443
2011 44.35 43.99 - 0.36 43.86 43.57 - 0.29 44.94 44.51 - 0.43 0.8067
2012 44.02 44.08 0.06 43.19 43.15 - 0.04 45.04 45.21 0.17 0.7235
2013 44.65 44.49 - 0.16 43.58 43.26 - 0.32 45.87 45.90 0.03 0.5488
2014 45.13 44.95 - 0.18 43.97 43.18 - 0.79 46.51 47.06 0.55 0.0265
2015 45.29 45.00 - 0.29 43.91 43.65 - 0.26 46.99 46.66 - 0.33 0.9039

Results were presented as least square means from baseline and follow-up for both groups and mean difference within each group.

* p-value <0.05 was considered statistically significant and numbers in bold indicate significant results.